Scalability
Ypsomed platforms are built to grow with our customers, from early clinical trials to large-scale commercial supply. With flexible infrastructure, global capacity, and integrated systems, we provide scalable solutions that meet our customers’ needs at every stage of the product lifecycle.
Fast to clinic, fast to market
Ypsomed's pre-validated platforms enable rapid entry into clinical development. For even faster starts, we also offer pre-configured platform variants that can be deployed immediately, providing early access without compromising future customization at the commercial stage.
Our manufacturing models are designed to support a full range of project scales and timelines. Clinical supply can start with just a few hundred units using semi-automated or manual processes. As demand increases, production scales seamlessly to high-output, fully automated lines delivering millions of units per year. Flexible business models accommodate different customer strategies, from low-volume pilot programs to large-scale commercial launches.
Supply chain resilience
With manufacturing sites in Switzerland, Germany, China, and soon the US, Ypsomed offers redundancy, geographic flexibility, and proximity to major markets. We are ready for what’s next, and our capacity planning ensures readiness for growth, without disruption, on a global scale.
Integrated manufacturing systems
All production equipment is connected through a central SAP ERP system, enabling efficient planning, real-time quality control, and traceability. This integrated setup supports smart manufacturing practices and ensures regulatory compliance across the board.
Strategic partnerships
Our strategic partner network extends across the full combination product supply chain, enhancing our ability to deliver reliable, end-to-end support at a global scale. By working with trusted partners that share aligned quality and performance standards, Ypsomed is able to complement its own manufacturing footprint with additional capacity and flexibility.
Expert insights on scalability
